NEW YORK (TheStreet) -- Shares of HCA (HCA) - Get Report were slumping in early-afternoon trading on Wednesday ahead of the company's 2016 third quarter earnings, due out before tomorrow's opening bell.
Wall Street is projecting that earnings and revenue will increase year-over-year.
Analysts surveyed by FactSet are forecasting adjusted earnings of $1.42 per share on revenue of $10.37 billion.
During the same quarter last year, the Nashville-based operator of hospital and healthcare facilities posted earnings of $1.17 per diluted share on revenue of $9.86 billion.
Yesterday, Wolfe Research initiated coverage of the stock with an "outperform" rating and $95 price target.
The firm believes HCA's quick-growing markets, significant investment and strong free cash flow make it the most attractive stock in its coverage for the short and medium term, the Fly reported.
Separately, TheStreet Ratings Team has a "Buy" rating with a score of B- on the stock.
The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, increase in net income, revenue growth and good cash flow from operations.
The team believes its strengths outweigh the fact that the company shows low profit margins.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
You can view the full analysis from the report here: HCA